RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

ENVESTNET ASSET MANAGEMENT INC's Holding History (CIK: 0001407543)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 121,443 Value ($000) $497 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 175,115 Value ($000) $855 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 189,901 Value ($000) $961 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 205,893 Value ($000) $1,089 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 231,756 Value ($000) $1,567 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 220,110 Value ($000) $1,451 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 144,136 Value ($000) $1,081 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 133,920 Value ($000) $1,335 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 127,440 Value ($000) $1,257 Avg Close $7.13 Range $4.97 - $11.17